VDAC1 and prostate carcinoma: The study of Lee et al. [37] showed that Drp1 binding to VDAC was significantly elevated in prostate cancer, which resulted in increased pyruvate transport to the mitochondria and affected mitochondrial metabolic processes such as oxidative phosphorylation and lipogenesis.